HBK Sorce Advisory’s MetLife MET Stock Holding History

HBK Sorce Advisory’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.64M	Sell	21,061 -858	-4%	-$64.2K	0.03%	176
2025 Q4	$1.67M	Sell	21,919 -40	-0.2%	-$3.17K	0.04%	175
2025 Q3	$1.79M	Buy	21,959 +337	+2%	+$26.5K	0.04%	154
2025 Q2	$1.74M	Sell	21,622 -813	-4%	-$62.7K	0.05%	154
2025 Q1	$1.8M	Sell	22,435 -6	-0%	-$499	0.05%	143
2024 Q4	$1.84M	Sell	22,441 -297	-1%	-$24.7K	0.06%	144
2024 Q3	$1.88M	Buy	22,738 +342	+2%	+$25.5K	0.06%	139
2024 Q2	$1.57M	Sell	22,396 -523	-2%	-$37.3K	0.05%	160
2024 Q1	$1.7M	Sell	22,919 -425	-2%	-$29.6K	0.06%	159
2023 Q4	$1.54M	Sell	23,344 -167	-0.7%	-$10.5K	0.06%	162
2023 Q3	$1.48M	Sell	23,511 -54	-0.2%	-$3.36K	0.07%	155
2023 Q2	$1.33M	Sell	23,565 -1,669	-7%	-$92.6K	0.06%	171
2023 Q1	$1.46M	Sell	25,234 -22,994	-48%	-$1.55M	0.07%	164
2022 Q4	$3.49M	Buy	48,228 +23,894	+98%	+$1.71M	0.09%	141
2022 Q3	$1.48M	Buy	24,334 +447	+2%	+$28.6K	0.1%	139
2022 Q2	$1.5M	Sell	23,887 -521	-2%	-$34.5K	0.11%	123
2022 Q1	$1.72M	Buy	24,408 +2,322	+11%	+$157K	0.09%	145
2021 Q4	$1.38M	Buy	22,086 +24	+0.1%	+$1.51K	0.07%	179
2021 Q3	$1.36M	Buy	22,062 +198	+0.9%	+$11.9K	0.08%	171
2021 Q2	$1.31M	Sell	21,864 -153	-0.7%	-$9.7K	0.07%	174
2021 Q1	$1.34M	Buy	22,017 +9,724	+79%	+$537K	0.08%	167
2020 Q4	$577K	Buy	12,293 +4,583	+59%	+$199K	0.04%	257
2020 Q3	$287K	Sell	7,710 -2,328	-23%	-$88.4K	0.02%	359
2020 Q2	$367K	Buy	10,038 +947	+10%	+$33K	0.03%	299
2020 Q1	$278K	Buy	9,091 +1,064	+13%	+$47.2K	0.03%	305
2019 Q4	$409K	Buy	8,027 +100	+1%	+$4.83K	0.04%	300
2019 Q3	$374K	Sell	7,927 -437	-5%	-$20.8K	0.04%	293
2019 Q2	$415K	Buy	8,364 +792	+10%	+$37.2K	0.04%	271
2019 Q1	$322K	Buy	7,572 +1,244	+20%	+$55K	0.03%	323
2018 Q4	$260K	Sell	6,328 -1,607	-20%	-$69K	0.03%	316
2018 Q3	$371K	Sell	7,935 -304	-4%	-$13.9K	0.04%	262
2018 Q2	$359K	Buy	8,239 +472	+6%	+$22K	0.04%	278
2018 Q1	$356K	Buy	7,767 +1,634	+27%	+$79.3K	0.04%	263
2017 Q4	$310K	Sell	6,133 -214	-3%	-$11.3K	0.04%	303
2017 Q3	$330K	Sell	6,347 -343	-5%	-$16.7K	0.05%	236
2017 Q2	$328K	Buy	+6,690	New	+$310K	0.05%	225
2017 Q1	–	Sell	-6,809	Closed	-$325K	–	372
2016 Q4	$327K	Sell	6,809 -527	-7%	-$24.2K	0.06%	214
2016 Q3	$290K	Buy	+7,336	New	+$276K	0.06%	218
2016 Q1	–	Sell	-4,749	Closed	-$204K	–	256
2015 Q4	$204K	Buy	+4,749	New	+$209K	0.05%	199

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HBK Sorce Advisory's MET Position: Q1 2026 in Review

HBK Sorce Advisory reduced its MetLife (MET) stake by 3.9% in Q1 2026, selling an estimated $64.2K and leaving 21,061 shares worth $1.64M. The position accounts for 0.03% of the portfolio, ranked #176.

HBK Sorce Advisory first reported a position in MET in Q4 2015 and has held it in 39 quarters since. The position peaked at $3.49M in Q4 2022. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

HBK Sorce Advisory held 21,061 shares of MetLife worth $1.64M as of Q1 2026.
HBK Sorce Advisory sold 858 MetLife shares in Q1 2026, an estimated $64.2K.
MetLife made up 0.03% of HBK Sorce Advisory's portfolio in Q1 2026, its #176 holding.
HBK Sorce Advisory first reported a position in MetLife in Q4 2015 and has held it in 39 quarters since.
HBK Sorce Advisory's MetLife position peaked at $3.49M in Q4 2022.
1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.